Clinical Trial Update: Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating whether pantoprazole affects glycemic control and post-prandial glucose in adults with Type 2 diabetes; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Dr. Waheed Rehman | Conditions: Diabetes Mellitus | Phase 3 | Status: UNKNOWN